TABLE 2.
Clinical and demographic features of Study population stratified according to baseline symptoms
| Respiratory only (N = 629) | Respiratory/ neurologic symptoms (N = 111) | Neurologic only (N = 108) | Stroke (N = 53) | P | |
|---|---|---|---|---|---|
| Male sex, N (%) | 409 (65.0) | 68 (61.3) | 56 (51.9) | 23 (43.4) | 0.001 |
| Age (years), median (IQR) | 63 (51–75) | 62 (52–76) | 72 (50–83) | 77 (68–85) | <0.001 |
| Ethnicity, N (%) | |||||
| Caucasian | 499 (79.3) | 91 (82.0) | 94 (87.0) | 52 (98.1) | 0.195 |
| Latino | 70 (11.1) | 15 (13.5) | 3 (2.8) | – | |
| MENA | 22 (3.5) | 1 (0.9) | 4 (3.7) | – | |
| Asian | 29 (4.6) | 4 (3.6) | 5 (4.6) | 1 (1.9) | |
| Black African | 9 (1.4) | – | 2 (1.9) | – | |
| Charlson Comorbidity Index, median (IQR) | 2 (1–4) | 2 (1–5) | 4 (1–5) | 5 (3–6) | <0.001 |
| Time to Hospital Admittance (days), median (IQR) | 7 (4–10) | 7 (5–10) | 1 (0–5) | 1 (0–5) | <0.001 |
| Body temperature at Hospital Admittance (°C), median (IQR) | 38.0 (37.1–38.5) | 38.0 (37.2–38.5) | 36.7 (36.0–37.6) | 36.3 (36.0–37.3) | 0.005 |
| Disease severity, N (%) | |||||
| Moderate | 325 (51.7) | 64 (57.7) | 88 (81.5) | 40 (75.5) | <0.001 |
| Severe | 88 (14.0) | 21 (18.9) | 12 (11.1) | 5 (9.4) | |
| Critical | 216 (34.3) | 26 (23.4) | 8 (7.4) | 8 (15.1) | |
| Overall in‐hospital mortality, N (%) | 133 (21.1) | 22 (19.8) | 16 (14.8) | 20 (37.7) | 0.010 |
Bold values refer to statistically significant factors in multivariate analysis.